Welcome, Guest
Username: Password: Remember me
CYTX Financial performance development
  • Page:
  • 1

TOPIC: Russell Reconstitution

Russell Reconstitution 27 Jun 2015 06:44 #4742

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3239
  • Thank you received: 1102
I knew that the Russell re-balancing is at the end of June, but I thought it wouldnt effect Cytori since they flew already last year out pf the Russell 2000, so the volume last night DID surprise somewhat and "smelled" like re-balancing.... :whistle:




And yes- they were still in the Microcap Index..., but now are OUT again..... :bash: :bang:


Russell DELETION list Microcap Index

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Russell Reconstitution 27 Jun 2015 09:48 #4744

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3239
  • Thank you received: 1102
Interestingly enough....

Cytori is not the only Cell Company disappearing from the Russel MicroCap Index, Stemcells Inc and Opexa Therapeutics were on the deletion list also.
STEM even suffered a 16% decline as a result, whilst Cytori and Opexa settled for 5%. All are penny stocks...i.e. below 1$.

That must have an impact too since Cytori´s market cap at 59 cents is still 82 Mio whilst a stem cell stock addition Capricor Therapeutics is valued lower than that at 76 Mio but a PPS of 4.50$ or so...

Capricor came on Nasdaq through a REVERSE MERGER, which means in 95% of all cases that the Company is scam. However seems to belong to the exception 5% if one looks at its portfolio of development products and its Principal Investigator -Timothy Henry, now at Cedars Sinai and also former PI of ATHENA.




And they use CIRM- like Stemcells Inc by the way...

The ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) trial is a Phase I/II trial evaluating the safety and efficacy of lead therapeutic candidate, CAP-1002 – Capricor’s allogeneic, off-the-shelf, cardiosphere-derived cell product. The trial is being sponsored by Capricor and is led by Drs. Timothy Henry and Rajendra Makkar of the Cedars-Sinai Heart Institute. The trial is expected to enroll up to 314 patients in total (Phase I n=14, Phase II n=up to 300) at approximately 25-40 sites across the U.S.
The Phase I portion of the trial was funded in part by the National Institutes of Health and completed enrollment in December 2013, and the Phase II portion of the trial is supported in large part by the California Institute for Regenerative Medicine (CIRM).

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Russell Reconstitution 27 Jun 2015 10:01 #4745

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3239
  • Thank you received: 1102
The below, were the after hours trades- which obviously also were all re-balancing driven.... :grin:

17:51 $ .5901 5,997
17:50 $ .5901 5,997 - Cancelled Trade
17:12 $ .59 5,572
16:55 $ .59 5,482
16:42 $ .59 8,153
16:42 $ .5901 5,997
16:39 $ .59 5,572
16:37 $ .5901 15,233
16:37 $ .5901 6,217
16:35 $ .5901 25,229
16:35 $ .5901 2,389
16:35 $ .5901 22,781
16:34 $ .5901 203,223
16:33 $ .5899 Low 6,046
16:33 $ .5901 47,980
16:33 $ .5901 8,854
16:32 $ .5899 1,314
16:32 $ .5901 107,834
16:31 $ .5901 3,609,223
16:29 $ .5901 190,900
16:28 $ .5901 285,455
16:28 $ .5901 215,532
16:26 $ .591 14,005
16:26 $ .5901 9,156
16:25 $ .59 78,054
16:25 $ .59 25,320
16:24 $ .59 211,380
16:23 $ .5901 683,898
16:21 $ .5901 144,651
16:21 $ .59 4,141
16:20 $ .59 1,122
16:09 $ .595 489
16:00 $ .59 2,000
16:00 $ .59 170,975


Read more: www.nasdaq.com/symbol/cytx/after-hours#ixzz3eH5YDdZ5

For the market makers and professional bank traders, the re-balancing always tend to be a lucrutive affair and is being worked on weeks in advance before the actual trading day when it occurs, which than obviously was June 27th this year. :bye:

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:

Russell Reconstitution 27 Jun 2015 20:33 #4749

  • myownhedgefund
  • myownhedgefund's Avatar
  • Offline
  • Platinum Boarder
  • Platinum Boarder
  • Posts: 2708
  • Thank you received: 199
Maybe Hedrick will get CIRM to fund his mystery new indication he hinted at on the last call "if the money is there" (paraphrasing) :KO:

Please Log in or Create an account to join the conversation.

  • Page:
  • 1
Time to create page: 0.157 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.

 

 

Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites